UPPSALA, Sweden, March 17, 2020 /PRNewswire/ --  Orexo AB (publ.), today hosts a Capital Market Day in Stockholm, Sweden. On the day the company will present an overview of the company's growth strategy, pharmaceutical pipeline and digital therapies. In the presentation of the pharmaceutical pipeline the company will present t

LEEDS, England, March 17, 2020 /PRNewswire/ -- 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces an update on the previously reported  interim data from an ongoing phase I/II clinical trial, in collabora

NORCROSS, Ga., March 17, 2020 /PRNewswire/ -- As part of ongoing efforts to protect our community, PruittHealth can confirm that its Athens, Georgia facility, PruittHealth – Grandview, has transferred a resident to a local hospital with symptoms similar to those associated with COVID-19. Tests have neither confirmed nor ruled out CO

IRVINE, Calif., March 16, 2020 /PRNewswire/ -- We are deeply concerned for the health of our members and employees during this COVID 19 crisis. We feel it is our responsibility to do what we can to reduce the spread of the virus and with that as our guide, have made the difficult decision to close all of our clubs to the public today, March 16th, until

SILVER SPRING, Md., March 16, 2020 /PRNewswire/ -- Today, the U.S. Food and Drug Administration took two additional significant diagnostic actions during the coronavirus outbreak (COVID-19) by issuing Emergency Use Authorizations (EUAs) to: Hologic for its Panther Fusion SARS-COV-2 Assay, and Laboratory Corporation of America (LabCorp) for its COVID-19 RT-PCR test.

WASHINGTON, March 16, 2020 /PRNewswire/ -- The Board of Governors of the National Press Club (NPC) voted unanimously Monday evening to suspend Club operations for a minimum of 14 days in an effort to mitigate the risks posed to the NPC community by the 2019 novel coronavirus, or COVID-19, pandemic. Included in the suspension of operations are the Fourth Estate and Reliab

SHANGHAI, March 16, 2020 /PRNewswire/ -- InxMed (Shanghai) Co., Ltd. ("InxMed" or "Company"), a clinical stage biotech company dedicated to developing innovative, individualized medicines with international impact, announced today that the company has dosed first patient in its Phase Ib clinical trial of IN10018 as monotherapy and in

FRANKLIN LAKES, N.J. and BIRMINGHAM, Ala., March 16, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and BioGX Inc, a molecular diagnostics company, today announced that the companies have submitted Emergency Use Authorization requests to th

SONGDO, South Korea, March 16, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) entered into a contract development and manufacturing agreement with APRINOIA Therapeutics to develop an anti-tau monoclonal antibody candidate to treat primary and secondary tauopathies, including Progressive Supranuclear Palsy and Alzheimer's disease, which are all currently incurable. The candid

NEW YORK, March 16, 2020 /PRNewswire/ -- MOTION PT Group has the solution for providing physical, occupational and speech therapy to patients during the global Coronavirus pandemic via their telerehabilitation program, MOTION on the GO.